pentosidine has been researched along with Fractures, Bone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hagino, H; Matsumoto, H; Moriwaki, K; Nagashima, H; Osaki, M; Wada, T | 1 |
| Kanai, T; Nakano, M; Oikawa, T; Saeki, C; Saito, M; Saruta, M; Torisu, Y; Tsubota, A | 1 |
| Ito, K; Koike, H; Matsui, H; Miyazawa, Y; Nomura, M; Sekine, Y; Shibata, Y; Suzuki, K; Syuto, T | 1 |
| Cleland, TP; Sroga, GE; Thomas, CJ; Vashishth, D | 1 |
| Clay Bunn, R; Creecy, A; Nyman, JS; Unal, M; Uppuganti, S; Voziyan, P | 1 |
| Falgayrac, G; Kerckhofs, G; Luyten, F; Marin, C; Papantonakis, G; Penel, G; Sels, K; Van der Schueren, B; van Lenthe, GH; Vandamme, K; Vangoitsenhoven, R | 1 |
| Bauer, DC; Black, DM; Cummings, SR; Feingold, KR; Garnero, P; Harris, TB; Hillier, TA; Resnick, HE; Schwartz, AV; Sellmeyer, DE; Strotmeyer, ES; Tylavsky, FA | 1 |
| Saito, M | 1 |
| Higuchi, T; Kuroda, T; Saito, M; Shiraki, M; Shiraki, Y; Tanaka, S | 1 |
| Marumo, K; Saito, M | 3 |
| Yamamoto, M | 1 |
| Bank, RA; Baumbach, BM; DeGroot, J; Hernandez, CJ; Hwu, PB; Keaveny, TM; Sakkee, AN; Tang, SY; van der Ham, F | 1 |
| Fukunaga, M; Kuroda, T; Nakamura, T; Saito, M; Shiraki, M; Tanaka, S | 1 |
| Takeuchi, Y | 1 |
6 review(s) available for pentosidine and Fractures, Bone
| Article | Year |
|---|---|
[Poor bone quality in diabetes and arterioscelerosis].
Topics: Animals; Arginine; Arteriosclerosis; Biomarkers; Bone Density; Collagen; Diabetes Complications; Diabetes Mellitus; Fractures, Bone; Glycation End Products, Advanced; Homocysteine; Humans; Lysine; Osteoporosis; Risk | 2009 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone quality in chronic kidney disease : enzymatic and non-enzymatic glycation or oxidation induced cross-links in bone].
Topics: Animals; Arginine; Bone and Bones; Bone Diseases, Metabolic; Chronic Disease; Collagen; Fractures, Bone; Glycation End Products, Advanced; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Lysine; Osteoporosis; Oxidative Stress; Risk | 2010 |
[Bone quality in lifestyle-related diseases].
Topics: Arginine; Bone and Bones; Collagen; Fractures, Bone; Glycation End Products, Advanced; Humans; Hyperglycemia; Hyperhomocysteinemia; Life Style; Lysine; Oxidative Stress; Risk; Vitamin B 6 Deficiency | 2011 |
[Roles of collagen enzymatic and advanced glycation end products associated crosslinking as a determinant of bone quality].
Topics: Arginine; Biomarkers; Bone and Bones; Collagen; Fractures, Bone; Glycation End Products, Advanced; Humans; Lysine; Risk Factors | 2011 |
[Diabetes mellitus and osteoporosis. Predictive candidate markers for fracture risk in diabetic patients].
Topics: Arginine; Diabetes Mellitus, Type 2; Fractures, Bone; Humans; Lysine; Osteoporosis; Risk Factors | 2012 |
[Assessment of bone quality with metabolic bone markers].
Topics: Alkaline Phosphatase; Amino Acids; Arginine; Biomarkers; Bone and Bones; Bone Resorption; Collagen Type I; Forecasting; Fractures, Bone; Homocysteine; Humans; Lysine; Osteocalcin; Osteogenesis; Peptides; Tensile Strength | 2007 |
10 other study(ies) available for pentosidine and Fractures, Bone
| Article | Year |
|---|---|
Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
Topics: Aged; Bone Density; Female; Fractures, Bone; Humans; Independent Living; Insulin-Like Growth Factor I; Male | 2023 |
Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.
Topics: Aged; Arginine; Biomarkers; Chronic Disease; Cross-Sectional Studies; Female; Fractures, Bone; Humans; Japan; Liver Diseases; Lysine; Male; Middle Aged; Prevalence | 2021 |
Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Arginine; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Lysine; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Retrospective Studies; Tartrate-Resistant Acid Phosphatase | 2017 |
Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Bone and Bones; Cell Survival; Collagen; Cortical Bone; Female; Fractures, Bone; Glycation End Products, Advanced; Humans; Hydroxyproline; Linear Models; Lysine; Male; Mass Spectrometry; Middle Aged; Risk; Young Adult | 2018 |
Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age.
Topics: Aging; Animals; Arginine; Bone Density; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Femur; Fractures, Bone; Lysine; Male; Mice; Spectrum Analysis, Raman; X-Ray Microtomography | 2018 |
Unraveling the compromised biomechanical performance of type 2 diabetes- and Roux-en-Y gastric bypass bone by linking mechanical-structural and physico-chemical properties.
Topics: Animals; Arginine; Biomechanical Phenomena; Bone and Bones; Diabetes Mellitus, Type 2; Female; Fractures, Bone; Gastric Bypass; Glycation End Products, Advanced; Humans; Lysine; Male; Mice; Mice, Obese; Obesity; Skeleton; Tomography, X-Ray Computed; Weight Loss | 2018 |
Pentosidine and increased fracture risk in older adults with type 2 diabetes.
Topics: Aged; Arginine; Bone Density; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fractures, Bone; Humans; Incidence; Lysine; Male; Prevalence; Risk Factors; Spinal Fractures | 2009 |
Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment.
Topics: Aged; Arginine; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Bone; Homocysteine; Humans; Lysine; Middle Aged; Osteoporosis; Proportional Hazards Models | 2011 |
Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links.
Topics: Age Factors; Aged; Aged, 80 and over; Amino Acids; Arginine; Bone Matrix; Collagen; Female; Fractures, Bone; Glycosylation; Humans; Lysine; Male; Middle Aged; Tensile Strength; Thoracic Vertebrae | 2005 |
Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures.
Topics: Aged; Arginine; Cohort Studies; Collagen; Collagen Type I; Female; Fractures, Bone; Glycation End Products, Advanced; Humans; Incidence; Japan; Lysine; Middle Aged; Peptides; Postmenopause; Risk; Spinal Injuries | 2008 |